Skip to main content

The BPL Global Medical Publications Team expects a record year in 2022

The Bio Products Laboratory (BPL) Global Medical Publications team expects a record year in 2022, with more scientific abstracts, posters, and manuscripts submitted or presented than in any year in the company’s history.  Presentations will include outputs from clinical trial data mining, health outcomes work, insurance claims database reviews, and collaborations with external clinical partners, all to further the scientific and clinical understanding of our medicines.

According to Eric Wolford, PharmD, Vice President, Global Medical, “We are so excited to expand this capability within BPL, and to exceed our own, unprecedented targets. These are the activities that help define BPL’s focus as a science-driven company.” 

Be on the lookout for data to be presented at ISTH in July, THSNA and NHF in August, and IGNS in September.